(SCL) Stepan - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8585861003
SCL: Surfactants, Polymers, Polyurethane, Emulsifiers, Flavors, Solubilizers, Chemicals
Stepan Company is a global manufacturer of specialty and intermediate chemicals, supplying a diverse range of products to various industries worldwide. The company's operations are structured into three main segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment is a significant contributor to the company's revenue, producing surfactants used in a broad array of consumer and industrial cleaning and disinfection products. These include detergents for washing clothes, dishes, carpets, and floors, as well as personal care products like shampoos and body washes. Additionally, the company's surfactants are utilized in other applications such as fabric softeners, germicidal quaternary compounds, disinfectants, and lubricating ingredients. They also play a crucial role in various industrial applications, including emulsifiers for spreading agricultural products and in latex systems, plastics, and composites.
The Polymers segment is another key area of focus for Stepan Company, with the production of polyurethane polyols that serve as a critical component in the manufacture of rigid foam for thermal insulation in the construction industry. These polyols are also used as a base raw material for coatings, adhesives, sealants, and elastomers (CASE). Furthermore, the company produces polyester resins, including both liquid and powdered products, which are used in a variety of CASE applications. Phthalic anhydride, another product offered by this segment, is used in unsaturated polyester resins, alkyd resins, and plasticizers for applications in construction materials, as well as components of automotive, boating, and other consumer products. This diversity in product offerings enables Stepan Company to cater to a wide range of industries and applications.
Stepan Company's Specialty Products segment rounds out its operations, focusing on the production of flavors, emulsifiers, and solubilizers for use in food, flavoring, nutritional supplement, and pharmaceutical applications. With a history dating back to 1932, Stepan Company has established itself as a reputable player in the specialty chemicals industry. Headquartered in Northbrook, Illinois, the company has built a strong presence in the global market, with its products being used in various end-products worldwide. For more information, one can visit the company's website at https://www.stepan.com. The company's common stock is listed on the NYSE under the ticker symbol SCL, with the ISIN US8585861003, and is classified under the GICS Sub Industry of Specialty Chemicals.
Additional Sources for SCL Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
SCL Stock Overview
Market Cap in USD | 1,356m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception | 1992-03-17 |
SCL Stock Ratings
Growth 5y | -56.6% |
Fundamental | 2.79% |
Dividend | 61.9% |
Rel. Strength Industry | -369 |
Analysts | 3.5/5 |
Fair Price Momentum | 57.07 USD |
Fair Price DCF | 133.42 USD |
SCL Dividends
Dividend Yield 12m | 2.30% |
Yield on Cost 5y | 1.60% |
Annual Growth 5y | 5.97% |
Payout Consistency | 100.0% |
SCL Growth Ratios
Growth Correlation 3m | -61% |
Growth Correlation 12m | -84.5% |
Growth Correlation 5y | -62.4% |
CAGR 5y | -7.06% |
CAGR/Mean DD 5y | -0.32 |
Sharpe Ratio 12m | -1.19 |
Alpha | -49.08 |
Beta | 0.76 |
Volatility | 26.78% |
Current Volume | 121.6k |
Average Volume 20d | 125.9k |
As of January 22, 2025, the stock is trading at USD 65.59 with a total of 121,580 shares traded.
Over the past week, the price has changed by +4.19%, over one month by -1.84%, over three months by -10.38% and over the past year by -28.13%.
Neither. Based on ValueRay Fundamental Analyses, Stepan is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 2.79 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SCL as of January 2025 is 57.07. This means that SCL is currently overvalued and has a potential downside of -12.99%.
Stepan has received a consensus analysts rating of 3.50. Therefor, it is recommend to hold SCL.
- Strong Buy: 0
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, SCL Stepan will be worth about 61.7 in January 2026. The stock is currently trading at 65.59. This means that the stock has a potential downside of -5.96%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 97 | 47.9% |
Analysts Target Price | 97 | 47.9% |
ValueRay Target Price | 61.7 | -6% |